Advanced
ZrOCl<sub>2</sub>.8H<sub>2</sub>O as an Efficient Catalyst for the Three-Component Synthesis of Triazoloindazoles and Indazolophthalazines
ZrOCl2.8H2O as an Efficient Catalyst for the Three-Component Synthesis of Triazoloindazoles and Indazolophthalazines
Journal of the Korean Chemical Society. 2013. Aug, 57(4): 472-475
Copyright © 2013, Korea Chemical Society
  • Received : March 13, 2013
  • Accepted : June 28, 2013
  • Published : August 20, 2013
Download
PDF
e-PUB
PubReader
PPT
Export by style
Article
Author
Metrics
Cited by
TagCloud
About the Authors
Hamid Reza Tavakoli
Department of Chemistry, Imam Hossein University, Tehran, Iran
Sayed Mojtaba Moosavi
Department of Chemistry, Imam Hossein University, Tehran, Iran
Ayoob Bazgir
Department of Chemistry, Shahid Beheshti University, G. C., Tehran 1983963113, Iran.

Abstract
An efficient and environmentally benign protocol for the three-component synthesis of triazoloindazoles and indazolophthalazines via condensation of dimedone, aldehydes and urazole or phthalhydrazide catalyzed by ZrOCl 2 .8H 2 O as an inexpensive and eco-friendly catalyst with high catalytic activity under solvent-free conditions is reported. This protocol provides a new and improved method for obtaining triazoloindazoles and indazolophthalazines in terms of good yields, simple experimental procedure and short reaction time.
Keywords
INTRODUCTION
Functionalized nitrogen-heterocycles play a prominent role in medicinal chemistry and they have been intensively used as scaffolds for drug development. 1,2 In this context heterocycles containing urazole or phthalazine moiety are of particular interest because of their pharmacological profile. Some urazole derivatives were found to have some biological as well as pharmaceutical activity, such as anti-cancer and hypolipidemic. 3 Urazole derivatives also exhibit anticonvulsant 4 or fungicidal activity. 5 These compounds are also used in the preparation of herbicides, 6 pesticides, 7 and insecticides. 8 Similarly, phthalazine derivatives were reported to possess anticonvulsant, 9 cardiotonic, 10 and vasorelaxant 11 activities. These compounds have also proved to be promising luminescence materials and fluorescence probes. 12 Thus, the synthesis of urazole and phthalazine derivatives is an important and useful task in organic chemistry.
The use of zirconium(IV) salts as an efficient Lewis acid for various transformations, has been well documented in the literature, because of their easy availability, moisture stability and low toxicity. 1315 Among the various types of Zr(IV) salts, particularly, ZrOCl 2 .8H 2 O has advantages of moisture stability, readily availability and easy handling. 14 Also, the low toxicity of ZrOCl 2 .8H 2 O is evident from their LD50 [LD50 (ZrOCl 2 .8H 2 O, oral rat) = 3500 mg/kg]. 15 Therefore, the application of ZrOCl 2 .8H 2 O in organic synthesis is of renewed interest.
As part of our research aimed at developing new methods for the preparation of biologically interesting heterocycles, 16,17 recently, for the first time we have reported synthesis of triazoloindazoles and indazolophthalazines via condensation of dimedone, aldehydes and urazole or phthalhydrazide in the presence of p -TSA as an acidic catalyst. 18,19 Very recently, these three-component protocols utilizing different types of catalysts have been reported. 2025 The reported methods show varying degrees of successes as well as limitations. Therefore, there still remains a high demand for the development of more general, efficient, economically viable, and eco-compatible protocol to assemble such scaffolds. Due to unique advantages of ZrOCl 2 .8H 2 O, the aim of our research described here was to develop the three-component synthesis of triazoloindazoles and indazolophthalazines employing ZrOCl 2 .8H 2 O as an efficient and mild Lewis acid catalyst.
EXPERIMENTAL
- General Procedure
A mixture of dimedone (1 mmol), aldehyde (1 mmol), urazole or phthalazide (1 mmol) and ZrOCl 2 .8H 2 O (30 mol%) was stirred at 80 ℃ for 1 h (the progress of the reaction was monitored by TLC). After completion, the reaction mixture was washed with H 2 O (5 ml) and EtOH (5 ml) to afford pure product 4 .
All the products are known and were fully characterized by a comparison with authentic samples (melting point) and IR spectra. 18,19
Selected characterization data:
6,7-Dihydro-6,6-dimethyl-2-phenyl-9-(4-chlorophenyl)-[1,2,4]-triazolo[1,2-a]indazole-1,3,8(2H,5H,9H)-trione (4b). White powder (87%); mp 164−166 ℃. IR (KBr) (ν max , cm -1 ): 2932, 1725, 1646, 1381; 1 H NMR (300 MHz, CDCl 3 ): δ H 1.21 (6H, s, 2CH 3 ), 2.33 (2H, s, CH 2 ), 2.88 (2H, AB system, J = 18.7 Hz, CH 2 ), 6.19 (1H, s, CH), 7.34−7.50 (9H, m, H-Ar). MS m/z : 421 (M + ). Anal. Calcd for C 23 H 20 ClN 3 O 3 : C, 65.48; H, 4.78; N, 9.96%. Found: C, 65.40; H, 4.74; N, 9.89%.
6,7-Dihydro-6,6-dimethyl-2-phenyl-9-(4-nitrophenyl)-[1,2,4]-triazolo[1,2-a]indazole-1,3,8(2H,5H,9H)-trione (4d). White powder (86%); mp 176−178 ℃. IR (KBr) (ν max , cm -1 ): 2957, 1786, 1714, 1660. 1 H NMR (300 MHz, CDCl 3 ): δ H 1.19 (3H, s, CH 3 ), 1.22 (3H, s, CH 3 ), 2.31 (2H, s, CH 2 ), 2.88 (2H, AB system, J = 18.7 Hz, CH 2 ), 6.32 (1H, s, CH), 7.40−8.18 (9H, m, H-Ar). MS m/z : 432 (M + ). Anal. Calcd for C 23 H 20 N 4 O 5 : C, 63.88; H, 4.66; N, 12.96%. Found: C, 63.81; H, 4.73; N, 12.90%.
3,4-Dihydro-3,3-dimethyl-13-phenyl-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-trione (6a). Yellow powder (82%). Mp 205−207 ℃; IR (KBr) (ν max , cm -1 ): 2952, 1666, 1571; 1 H NMR (300 MHz, CDCl 3 ): δ H 1.21 (6H, s, 2Me), 2.36 (2H, s, CH 2 ), 3.23 and 3.43 (2H, AB system, J = 18.4 Hz, CH 2 ), 6.42 (1H, s, CHN), 7.33−8.35 (9H, m, Ph); MS, m/z : 372 (M + ). Anal. Calcd for C 23 H 20 N 2 O 3 : C, 74.18; H, 5.41; N, 7.52%. Found: C, 74.24; H, 5.46; N, 7.44%.
3,4-Dihydro-3,3-dimethyl-13-(4-chlorophenyl)-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-trione (6b). White powder (89%); mp 261−263 ℃; IR (KBr) (ν max , cm -1 ): 2925, 1653, 1620; 1 H NMR (300 MHz, CDCl 3 ): δ H 1.22 (3H, s, Me), 1.24 (3H, s, Me), 2.32 (2H, s, CH 2 ), 3.22 and 3.39 (2H, AB system, J = 18.6 Hz, CH 2 ), 6.45 (1H, s, CHN), 7.29−8.30 (8H, m, Ph); MS, m/z : 406 (M + ). Anal. Calcd for C 23 H 19 ClN 2 O 3 : C, 67.90; H, 4.71; N, 6.89%. Found: C, 67.97; H, 4.65; N, 6.83%.
RESULTS AND DISCUSSION
Initially, the reaction of dimedone 1 (1 mmol), urazole 2 (1 mmol) and benzaldehyde 3a (1 mmol) as a simple model substrate in the presence of ZrOCl 2 .8H 2 O in different solvents and under solvent-free conditions was investigated to optimize the reaction conditions ( 1 ). It was found that the reaction under solvent-free conditions after 1 h resulted in the higher isolated yield ( 1 ). Similarly, the molar ratio of ZrOCl 2 .8H 2 O was studied with the optimum amount being 30 mol% (entry 5). When this reaction was carried out without ZrOCl 2 .8H 2 O the yield of the expected product was trace (entry 8).
PPT Slide
Lager Image
Screening of the reaction conditions
PPT Slide
Lager Image
Screening of the reaction conditions
Using the optimized conditions, the generality of this reaction was examined using several types of aromatic aldehydes 3a−h . In all cases, the reactions gave the corresponding products in good isolated yields ( 2 ). These reactions proceeded very cleanly under mild conditions and no side reactions were observed.
Synthesis of triazoloindazole-triones4
PPT Slide
Lager Image
aIsolated yield after recycling of catalyst
Synthesis of indazolophthalazine-triones6
PPT Slide
Lager Image
Synthesis of indazolophthalazine-triones 6
Another advantage of this approach could be related to the reusability of the catalyst. We found that the catalyst could be separated from the reaction mixture simply by washing with water and reused after washing with CH 2 Cl 2 and dried at 60 ℃. The reusability of the catalyst was checked by the reaction of dimedone 1 , urazole 2 and benzaldehyde 3a under optimized reaction conditions. The results show that the catalyst can be used effectively three times without any loss of its activity ( 2 , entry 1). Therefore, the recyclability of the catalyst makes the process economically and potentially viable for commercial applications.
To further explore the potential of ZrOCl 2 .8H 2 O, we investigated reaction of phthalhydrazide 5 and dimedone 1 with aldehydes 3 and obtained 2 H -indazolo[2,1- b ]phthalazine-1,6,11(13 H )-trione 6 in good isolated yields under the same reaction conditions ( 3 ).
CONCLUSION
In conclusion, we have demonstrated that ZrOCl 2 .8H 2 O can be used as green and reusable catalyst for efficient synthesis of triazoloindazoles and indazolophthalazines under solvent-free conditions. Moreover, the cheapness, easy availability of the reagent, easy and clean workup makes this method attractive for organic chemist.
Acknowledgements
We are grateful for financial support from the Research Council of Shahid Beheshti University. And the publication cost of this paper was supported by the Korean Chemical Society.
References
Hulme C. 2005 In Multicomponent Reactions; Zhu, J., Bienayme, H., Eds. Wiley Weinheim
Garuti L. , Roberti M. , Pizzirani D. 2007 Mini-Rev. Med. Chem. 7 481 - 489    DOI : 10.2174/138955707780619626
Izydore R. A. , Hall I. H. 1989 Method for control of hyperlipidemia, U.S. Patent 4,866,058 Chem. Abstr. 112 151876X -
Jacobson C. R. , D’Adamo A. , Cosgrove C. E. 1972 U.S. Patent 3,663,564 Chem. Abstr. 76 34259a -
Shgematsu T. , Tomita M. , Shibahara T. , Nakazawa M. , Munakata S. 1977 Jpn. Patent 52,083,562 Chem. Abstr. 87 168017f -
Wakabayashi O. , Matsuya K. , Ohta H. , Jikihara T. , Suzuki S. 1976 Ger Offen. 2,526,358 Chem. Abstr. 84 135700h -
Ovadia D. , Peleg N. , Bracha P. 1978 N-haloalkylmio urazole pesticides, U.S. Patent 4,087,534 Chem. Abstr. 89 109513h -
Von Bredow B. , Brechbuehler H. 1974 Ger Offen. 2,343,347 Chem. Abstr. 80 140210s -
Grasso S. , DeSarro G. , Micale N. , Zappala M. , Puia G. , Baraldi M. , Demicheli C. 2000 J. Med. Chem. 43 2851 -    DOI : 10.1021/jm001002x
Nomoto Y. , Obase H. , Takai H. , Teranishi M. , Nakamura J. , Kubo K. 1990 Chem. Pharm. Bull. (Tokyo) 38 2179 -    DOI : 10.1248/cpb.38.2179
Watanabe N. , Kabasawa Y. , Takase Y. , Matsukura M. , Miyazaki K. , Ishihara H. , Kodama K. , Adachi H. 1998 J. Med. Chem. 41 3367 -    DOI : 10.1021/jm970815r
Wu H. , Chen X. M. , Wan Y. , Xin H. Q. , Xu H. H. , Ma R. , Yue C. H. , Pang L. L. 2009 Lett. Org. Chem. 6 219 -    DOI : 10.2174/157017809787893127
Firouzabadi H. , Jafarpour M. 2008 J. Iran. Chem. Soc. 5 159 -    DOI : 10.1007/BF03246110
Ghosh R. , Maiti, S. Chakraborty A. 2005 Tetrahedron Lett 46 147 -    DOI : 10.1016/j.tetlet.2004.10.164
Mirkhani V. , Mohammadpoor-Baltork I. , Moghadam M. , Tangestaninejad S. , Abdollahi-Alibeik M. , Kargar H. 2007 Appl. Catal., A 325 99 -    DOI : 10.1016/j.apcata.2007.03.016
Ghahremanzadeh R. , Amanpour T. , Bazgir A. 2010 Tetrahedron Lett 51 4202 -    DOI : 10.1016/j.tetlet.2010.06.014
Noroozi Tisseh Z. , Dabiri M. , Nobahar M. , Abolhasani Soorki A. , Bazgir A. 2012 Tetrahedron 68 3351 -    DOI : 10.1016/j.tet.2012.02.051
Bazgir, A. Seyyedhamzeh M. , Yasaei Z. , Mirzaei P. 2007 Tetrahedron Lett 48 8790 -    DOI : 10.1016/j.tetlet.2007.10.084
Sayyafi M. , Seyyedhamzeh M. , Khavasi H. R. , Bazgir A. 2008 Tetrahedron 64 2375 -    DOI : 10.1016/j.tet.2008.01.006
Sayyafi M. , Seyyedhamzeh M. , Khavasi H. R. , Bazgir A. 2011 Tetrahedron 67 390 -    DOI : 10.1016/j.tet.2010.11.029
Hamidian H. , Fozooni S. , Hassankhani A. , Mohammadi S. 2011 Molecules 16 9041 -    DOI : 10.3390/molecules16119041
Adharvana Chari M. , Karthikeyan G. , Pandurangan A. , Siddulu Naidu T. , Sathyaseelan B. , Javaid Zaidi S. M. , Vinu A. 2010 Tetrahedron Lett 51 2629 -    DOI : 10.1016/j.tetlet.2010.03.021
Shekouhy M. , Hasaninejad A. 2012 Ultrason. Sonochem. 19 307 -    DOI : 10.1016/j.ultsonch.2011.07.011
Shukla G. , Verma R. K. , Verma G. K. , Singh M. S. 2011 Tetrahedron Lett 52 7195 -    DOI : 10.1016/j.tetlet.2011.10.136
Ghorbani-Vaghei R. , Karimi-Nami R. , Toghraei-Semiromi Z. , Amiri M. , Ghavidel M. 2011 Tetrahedron 67 1930 -    DOI : 10.1016/j.tet.2011.01.024